SynthesisCNS drugs2015

Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.

Gyanendra Kumar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.